|
|
 |
International Clinical Trials in Rheumatology
Argentina
Australia
Austria
Belgium
Brazil
Bulgaria
Canada
- Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
Montreal, QC; Research Site:
- Psoriasis and Psoriatic Disorders: A topical treatment for body psoriasis in adolescents
St. John's, Newfoundland; Newlab Clinical Research, Inc.
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Burlington, ON; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Calgary, AB; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Ottawa, ON; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Quebec City, QC; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Sherbrooke, QC; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
St John'S; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Toronto, ON; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Trois-Rivieres, QC; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Vancouver, BC; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Hamilton, ON; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Kitchener, ON; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Saskatoon, SK; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
Edmonton, AB; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
Hamilton, ON; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
Kelowna, BC; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
Laval, QC; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
Mississauga, ON; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
Montreal, QC; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
Nepean, ON; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
Ottawa, ON; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
Quebec City, QC; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
Sainte-Foy, QC; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
Sherbrooke, QC; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
St John'S; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
St-Eustache, QC; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
Thunder Bay, ON; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
Toronto, ON; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
Trois-Rivieres, QC; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
Vancouver, BC; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
Victoria, BC; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
Windsor, ON; Research Site:
- Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
Winnipeg, MB; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Calgary, AB; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Hamilton, ON; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Ottawa, ON; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Winnipeg, MB; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Edmonton, AB; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Hamilton, ON; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Kitchener, ON; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
London, ON; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Mississauga, ON; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Montreal, QC; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Ottawa, ON; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Quebec City, QC; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Toronto, ON; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Trois-Rivieres, QC; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Vancouver, BC; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Winnipeg, MB; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Hamilton, ON; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Kitchener, ON; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
London, ON; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Sainte-Foy, QC; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Toronto, ON; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Trois-Rivieres, QC; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Vancouver, BC; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Victoria, BC; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis.
Calgary, AB; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis.
Edmonton, AB; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis.
London, ON; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis.
Quebec City, QC; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis.
Sherbrooke, QC; Research Site:
- Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis.
Toronto, ON; Research Site:
- Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
Edmonton, AB; Research Site:
- Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
Mississauga, ON; Research Site:
- Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
Ottawa, ON; Research Site:
- Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
Pointe-Claire, QC; Research Site:
- Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
Sainte-Foy, QC; Research Site:
- Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
St John'S; Research Site:
- Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
Toronto, ON; Research Site:
- Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
Winnipeg, MB; Research Site:
- Rheumatoid Arthritis: A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis
Edmonton, AB; Research Site:
- Rheumatoid Arthritis: A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis
Halifax, NS; Research Site:
- Rheumatoid Arthritis: A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis
Ottawa, ON; Research Site:
- Rheumatoid Arthritis: A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis
Toronto, ON; Research Site:
- Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
London, ON; Research Site:
- Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Newmarket, ON; Research Site:
- Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Penticton, BC; Research Site:
- Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Toronto, ON; Research Site:
- Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Trois-Rivieres, QC; Research Site:
- Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Victoria, BC; Research Site:
- Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Winnipeg, MB; Research Site:
- Rheumatoid Arthritis: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
Edmonton, AB; Research Site:
- Rheumatoid Arthritis: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
Hamilton, ON; Research Site:
- Rheumatoid Arthritis: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
Mississauga, ON; Research Site:
- Rheumatoid Arthritis: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
Ottawa, ON; Research Site:
- Rheumatoid Arthritis: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
Sainte-Foy, QC; Research Site:
- Rheumatoid Arthritis: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
Sherbrooke, QC; Research Site:
- Rheumatoid Arthritis: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
St. John's, NL; Research Site:
- Rheumatoid Arthritis: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
Vancouver, BC; Research Site:
- Rheumatoid Arthritis: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
Winnipeg, MB; Research Site:
- Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
Burlington, ON; Research Site:
- Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
Calgary, AB; Research Site:
- Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
Montreal, QC; Research Site:
- Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
Newmarket, ON; Research Site:
- Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
Ottawa, ON; Research Site:
- Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
Sainte-Foy, QC; Research Site:
- Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
St John'S; Research Site:
- Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
Toronto, ON; Research Site:
- Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
Victoria, BC; Research Site:
- Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
Winnipeg, MB; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Hamilton, ON; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Ottawa, ON; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Quebec City, QC; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Saskatoon, SK; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Winnipeg, MB; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Burlington, ON; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Calgary, AB; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Montreal, QC; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Newmarket, ON; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Ottawa, ON; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Sainte-Foy, QC; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
St John'S; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Toronto, ON; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Vancouver, BC; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Victoria, BC; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Winnipeg, MB; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Burlington, ON; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Calgary, AB; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Edmonton, AB; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Kitchener, ON; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
London, ON; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Mississauga, ON; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Montreal, QC; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Newmarket, ON; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Sainte-Foy, QC; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Toronto, ON; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Winnipeg, MB; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
Calgary, AB; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
London, ON; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
St John'S; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
Vancouver, BC; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
Calgary, AB; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
St John'S; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
Vancouver, BC; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
Calgary, AB; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
Edmonton, AB; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
Hamilton, ON; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
London, ON; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
Toronto, ON; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
Burlington, ON; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
Hamilton, ON; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
Kitchener, ON; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
Mississauga, ON; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
Ottawa, ON; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
Sainte-Foy, QC; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
St John'S; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
Victoria, BC; Research Site:
- Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
Winnipeg, MB; Research Site:
- Rheumatoid Arthritis: A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Calgary, AB; Research Site:
- Rheumatoid Arthritis: A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Edmonton, AB; Research Site:
- Rheumatoid Arthritis: A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Hamilton, ON; Research Site:
- Rheumatoid Arthritis: A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
London, ON; Research Site:
- Rheumatoid Arthritis: A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Toronto, ON; Research Site:
- Rheumatoid Arthritis: A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Vancouver, BC; Research Site:
- Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Burlington, ON; Research Site:
- Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Calgary, AB; Research Site:
- Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Edmonton, AB; Research Site:
- Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Hamilton, ON; Research Site:
- Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Kitchener, ON; Research Site:
- Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
London, ON; Research Site:
- Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Mississauga, ON; Research Site:
- Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Montreal, QC; Research Site:
- Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Ottawa, ON; Research Site:
- Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Quebec City, QC; Research Site:
- Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Sainte-Foy, QC; Research Site:
- Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Saskatoon, SK; Research Site:
- Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
St John'S; Research Site:
- Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Toronto, ON; Research Site:
- Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Victoria, BC; Research Site:
- Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Winnipeg, MB; Research Site:
- Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
Montreal, QC; Research Site:
- Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
Ottawa, ON; Research Site:
- Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
Quebec City, QC; Research Site:
- Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
Saskatoon, SK; Research Site:
- Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
St John'S; Research Site:
- Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
Toronto, ON; Research Site:
- Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
Winnipeg, MB; Research Site:
- Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
Kitchener, ON; Research Site:
- Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
Toronto, ON; Research Site:
- Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
London, ON; Research Site:
- Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
Montreal, QC; Research Site:
- Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
Sherbrooke, QC; Research Site:
- Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
Toronto, ON; Research Site:
- Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
Vancouver, BC; Research Site:
Chile
China
Colombia
Costa Rica
Croatia
Czech Republic
| |
